Clinical Trials Browser

Phase 2 × Small Cell Lung Carcinoma × beta-D-glucosylisophosphoramide mustard × Clear all

NCT00435578 2009-04-30

Safety and Efficacy Study of Glufosfamide in Patients With Recurrent Sensitive Small Cell Lung Carcinoma

Phase 2 Terminated

Small Cell Lung Carcinoma